{"id":"W2607028219","doi":"10.1093/jnci/94.19.1458","title":"A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma","year":2002,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Bone health and treatments","field":"Medicine","cited_by":1657,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôtel-Dieu de Québec; London Health Sciences Centre; Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Oncology; Placebo; Internal medicine; Randomized controlled trial; Refractory (planetary science); Prostate carcinoma; Prostate; Urology; Cancer; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03240713673957241,"score_gpt":0.3037480515177607,"score_spread":0.2713409147781883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}